1. Home
  2. MXCT vs EHAB Comparison

MXCT vs EHAB Comparison

Compare MXCT & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • EHAB
  • Stock Information
  • Founded
  • MXCT 1999
  • EHAB 2014
  • Country
  • MXCT United States
  • EHAB United States
  • Employees
  • MXCT N/A
  • EHAB N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EHAB Hospital/Nursing Management
  • Sector
  • MXCT Health Care
  • EHAB Health Care
  • Exchange
  • MXCT Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • MXCT 398.3M
  • EHAB 397.2M
  • IPO Year
  • MXCT 2021
  • EHAB N/A
  • Fundamental
  • Price
  • MXCT $3.45
  • EHAB $7.47
  • Analyst Decision
  • MXCT Strong Buy
  • EHAB Hold
  • Analyst Count
  • MXCT 3
  • EHAB 6
  • Target Price
  • MXCT $8.67
  • EHAB $9.05
  • AVG Volume (30 Days)
  • MXCT 599.5K
  • EHAB 412.5K
  • Earning Date
  • MXCT 11-06-2024
  • EHAB 11-06-2024
  • Dividend Yield
  • MXCT N/A
  • EHAB N/A
  • EPS Growth
  • MXCT N/A
  • EHAB N/A
  • EPS
  • MXCT N/A
  • EHAB N/A
  • Revenue
  • MXCT $45,599,000.00
  • EHAB $1,037,200,000.00
  • Revenue This Year
  • MXCT N/A
  • EHAB $2.55
  • Revenue Next Year
  • MXCT $21.59
  • EHAB $3.63
  • P/E Ratio
  • MXCT N/A
  • EHAB N/A
  • Revenue Growth
  • MXCT 19.85
  • EHAB N/A
  • 52 Week Low
  • MXCT $3.17
  • EHAB $6.85
  • 52 Week High
  • MXCT $5.55
  • EHAB $11.74
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 44.48
  • EHAB 50.08
  • Support Level
  • MXCT $3.17
  • EHAB $6.97
  • Resistance Level
  • MXCT $3.61
  • EHAB $8.09
  • Average True Range (ATR)
  • MXCT 0.25
  • EHAB 0.37
  • MACD
  • MXCT -0.01
  • EHAB -0.01
  • Stochastic Oscillator
  • MXCT 28.93
  • EHAB 40.53

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.

Share on Social Networks: